PAIRED: Quantitative and Qualitative PAtIent-Reported Experiences and perceiveD Benefit of Treatment with Dolutegravir/Lamivudine in the United States
A large representative population with HIV had primarily positive experiences and few needs after switching to DTG/3TC. These data complement clinical trial data and support DTG/3TC effectiveness and tolerability in real-world settings.
Authors
- Katie Mycock (ORCID: https://orcid.org/0000-0001-9454-134X)
- Deanna Merrill
- Gustavo Verdier
- Abigail McMillan (ORCID: https://orcid.org/0000-0002-0289-4955)
- Jihad Slim (ORCID: https://orcid.org/0000-0002-4192-7246)
- Gavin Harper (ORCID: https://orcid.org/0000-0002-1704-9447)
- Andrew P. Brogan
Institutions
- ViiV Healthcare (Spain) (ES)
- Adelphi Group (United Kingdom) (GB)
- Saint Michael's Medical Center (US)
Publication Details
- Journal
- Patient
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1007/s40271-025-00779-x
- Citations
- 1
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- ViiV Healthcare